Breaking News, Collaborations & Alliances

Societal CDMO Partners with Atossa Therapeutics

CTS activities will focus on analytic method transfer, manufacturing of R&D engineering batches.

Societal CDMO, Inc., a contract development and manufacturing organization (CDMO) dedicated to solving complex formulation and manufacturing challenges primarily in small molecule therapeutic development, has been selected by Atossa Therapeutics to provide a range of its clinical trial services (CTS) offerings focused on Atossa’s proprietary selective estrogen receptor modulator (SERM), (Z)-endoxifen. The agreement spans a range of activities including analytical method transfer/development a...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters